Chronic hepatitis B: treatment alert
- 7 November 2006
- journal article
- Published by Wiley in Liver International
- Vol. 26 (S2) , 47-58
- https://doi.org/10.1111/j.1478-3231.2006.01374.x
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Management of chronic hepatitis B in challenging patient populationsLiver International, 2006
- New therapies for chronic hepatitis B infectionLiver International, 2006
- Factors influencing liver disease progression in chronic hepatitis BLiver International, 2006
- Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral LoadGastroenterology, 2006
- Virologic response and resistance to adefovir in patients with chronic hepatitis BJournal of Hepatology, 2005
- Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapyGut, 2005
- SHORT STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTSJournal of Hepatology, 2005
- Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: A longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baselineJournal of Hepatology, 2005
- Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis BNew England Journal of Medicine, 2004
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999